Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:48 AM
Ignite Modification Date:
2025-12-26 @ 11:48 AM
NCT ID:
NCT00688116
Eligibility Criteria:
Inclusion Criteria:
* Patients must be documented to be refractory or not candidates for current approved therapies. - Must have anECOG status 0-2. - Peripheral neuropathy ?2.
* Must have acceptable organ and marrow function per protocol parameters.
* No clinically significant ventricular arrythmias or ischemia.
Exclusion Criteria:
* Must not be pregnant or breastfeeding. -No chemotherapy or radiation within 3 weeks..
* No previous radiation to \>25% of total bone marrow.
* No previous high dose chemotherapy with autologous or allogeniec hematopoietic stem cell transplantation.
* No primary brain tumors or active brain metastases.
* No use of any investigational agents within 4 weeks.
* No treatment with chronic immunosuppressants.
* No uncontrolled, intercurrent illness.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
25 Years
Study:
NCT00688116
Study Brief:
Protocol Section:
NCT00688116